Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ligand Pharmaceuticals Incorporated LGND

Full chart Compare
Set alert

Price alert · LGND

All alert types
316.13 USD +2.61 (+0.83%)

At closeNov 4, 2026, 4:00 PM EST

316.13 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

309.86 Day range 319.18
175.89 52-week range 326.63
YTD
+67.20%
1 year
+66.87%

Financial health

Altman Z-Score

3.56 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 29.4×
FY 2016: -808×FY 2017: 142×FY 2018: 14.2×FY 2019: 2.0×FY 2020: -345×FY 2021: 27.8×FY 2022: -33.7×FY 2023: 23.6×FY 2024: -487×FY 2025: 29.4×
FY 2016 5y median 23.6× FY 2025
P/S 13.6×
FY 2016: 12.1×FY 2017: 12.7×FY 2018: 8.1×FY 2019: 10.3×FY 2020: 6.1×FY 2021: 6.6×FY 2022: 5.7×FY 2023: 9.4×FY 2024: 11.7×FY 2025: 13.6×
FY 2016 5y median 9.4× FY 2025
P/B 3.6×
FY 2016: 3.6×FY 2017: 4.3×FY 2018: 3.6×FY 2019: 1.6×FY 2020: 1.4×FY 2021: 2.0×FY 2022: 1.9×FY 2023: 1.8×FY 2024: 2.4×FY 2025: 3.6×
FY 2016 5y median 2.0× FY 2025
P/FCF 74.8×
FY 2016: 38.1×FY 2017: 20.8×FY 2018: 11.2×FY 2019: -38.8×FY 2020: 20.0×FY 2021: 22.9×FY 2022: 9.4×FY 2023: -289×FY 2024: 25.3×FY 2025: 74.8×
FY 2016 5y median 22.9× FY 2025
EV/EBITDA 20.4×
FY 2016: 25.2×FY 2017: 22.6×FY 2018: 8.3×FY 2019: 2.1×FY 2020: 24.9×FY 2021: 13.4×FY 2022: 14.4×FY 2023: 12.1×FY 2024: 46.4×FY 2025: 20.4×
FY 2016 5y median 14.4× FY 2025
EV/Sales 14.7×
FY 2016: 12.8×FY 2017: 12.9×FY 2018: 7.8×FY 2019: 15.1×FY 2020: 8.6×FY 2021: 7.9×FY 2022: 6.0×FY 2023: 9.3×FY 2024: 11.3×FY 2025: 14.7×
FY 2016 5y median 9.3× FY 2025
FCF Yield 1.3%
FY 2016: 2.6%FY 2017: 4.8%FY 2018: 8.9%FY 2019: -2.6%FY 2020: 5.0%FY 2021: 4.4%FY 2022: 10.6%FY 2023: -0.3%FY 2024: 3.9%FY 2025: 1.3%
FY 2016 5y median 3.9% FY 2025

Profitability

Gross Margin 97.5%
FY 2016: 94.9%FY 2017: 96.2%FY 2018: 97.5%FY 2019: 90.6%FY 2020: 81.4%FY 2021: 74.3%FY 2022: 73.1%FY 2023: 73.3%FY 2024: 93.4%FY 2025: 97.5%
FY 2016 5y median 74.3% FY 2025
Operating Margin 17.6%
FY 2016: 40.3%FY 2017: 48.2%FY 2018: 65.1%FY 2019: 671.0%FY 2020: 22.9%FY 2021: 43.0%FY 2022: 1.5%FY 2023: 9.1%FY 2024: -13.5%FY 2025: 17.6%
FY 2016 5y median 9.1% FY 2025
Net Margin 46.4%
FY 2016: -1.5%FY 2017: 8.9%FY 2018: 57.0%FY 2019: 523.2%FY 2020: -1.8%FY 2021: 23.7%FY 2022: -17.0%FY 2023: 39.7%FY 2024: -2.4%FY 2025: 46.4%
FY 2016 5y median 23.7% FY 2025
ROE 12.2%
FY 2016: -0.4%FY 2017: 3.0%FY 2018: 25.6%FY 2019: 82.0%FY 2020: -0.4%FY 2021: 7.0%FY 2022: -5.6%FY 2023: 7.4%FY 2024: -0.5%FY 2025: 12.2%
FY 2016 5y median 7.0% FY 2025
ROIC 2.4%
FY 2016: -2.2%FY 2017: 2.3%FY 2018: 11.2%FY 2019: 43.1%FY 2020: 3.0%FY 2021: 8.3%FY 2022: -0.1%FY 2023: 1.3%FY 2024: 4.0%FY 2025: 2.4%
FY 2016 5y median 2.4% FY 2025
ROA 8.0%
FY 2016: -0.3%FY 2017: 1.9%FY 2018: 11.4%FY 2019: 42.1%FY 2020: -0.2%FY 2021: 4.4%FY 2022: -4.4%FY 2023: 6.6%FY 2024: -0.4%FY 2025: 8.0%
FY 2016 5y median 4.4% FY 2025

Growth (YoY)

Revenue 60.4%
FY 2016: 51.5%FY 2017: 29.5%FY 2018: 78.2%FY 2019: -52.2%FY 2020: 36.0%FY 2021: 47.7%FY 2022: -18.8%FY 2023: -33.1%FY 2024: 27.3%FY 2025: 60.4%
FY 2016 FY 2025
Operating Income 308.8%
FY 2016: 60.6%FY 2017: 55.1%FY 2018: 140.5%FY 2019: 392.9%FY 2020: -95.4%FY 2021: 176.9%FY 2022: -97.1%FY 2023: 293.2%FY 2024: -289.3%FY 2025: 308.8%
FY 2016 FY 2025
EPS (diluted) 2886.4%
FY 2016: -100.6%FY 2017: 775.2%FY 2018: 1024.5%FY 2019: 434.4%FY 2020: -100.6%FY 2021: 1955.6%FY 2022: -159.3%FY 2023: 248.5%FY 2024: -107.5%FY 2025: 2886.4%
FY 2016 FY 2025
Free Cash Flow -36.8%
FY 2016: 12.4%FY 2017: 149.2%FY 2018: 110.8%FY 2019: -117.5%FY 2020: 257.2%FY 2021: 39.7%FY 2022: 71.2%FY 2023: -103.6%FY 2024: 1912.0%FY 2025: -36.8%
FY 2016 FY 2025

Financial Health

Current Ratio 22.2×
FY 2016: 0.7×FY 2017: 1.0×FY 2018: 10.6×FY 2019: 66.1×FY 2020: 5.0×FY 2021: 11.2×FY 2022: 2.7×FY 2023: 14.1×FY 2024: 8.9×FY 2025: 22.2×
FY 2016 5y median 11.2× FY 2025
Quick Ratio 22.0×
FY 2016: 0.7×FY 2017: 1.0×FY 2018: 10.5×FY 2019: 65.7×FY 2020: 4.7×FY 2021: 10.5×FY 2022: 2.5×FY 2023: 12.7×FY 2024: 8.6×FY 2025: 22.0×
FY 2016 5y median 10.5× FY 2025
Debt / Equity 0.4×
FY 2016: 0.6×FY 2017: 0.5×FY 2018: 1.1×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 0.4×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.4×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 1.3×FY 2017: 0.3×FY 2018: -0.3×FY 2019: 0.7×FY 2020: 7.2×FY 2021: 2.1×FY 2022: 0.5×FY 2023: -0.2×FY 2024: -1.6×FY 2025: 1.4×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 10.0×
FY 2016: 3.6×FY 2017: 6.0×FY 2018: 3.4×FY 2019: 22.6×FY 2020: 1.4×FY 2021: 5.3×FY 2022: 1.7×FY 2023: 18.2×FY 2024: -7.4×FY 2025: 10.0×
FY 2016 5y median 5.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31